KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Merck (MRK) Equity Average (2016 - 2025)

Historic Equity Average for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $50.5 billion.

  • Merck's Equity Average rose 1446.47% to $50.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $50.5 billion, marking a year-over-year increase of 1446.47%. This contributed to the annual value of $42.0 billion for FY2024, which is 37.52% up from last year.
  • Per Merck's latest filing, its Equity Average stood at $50.5 billion for Q3 2025, which was up 1446.47% from $48.7 billion recorded in Q2 2025.
  • Over the past 5 years, Merck's Equity Average peaked at $50.5 billion during Q3 2025, and registered a low of $26.2 billion during Q1 2021.
  • Its 5-year average for Equity Average is $41.3 billion, with a median of $42.1 billion in 2022.
  • Per our database at Business Quant, Merck's Equity Average soared by 5104.02% in 2022 and then crashed by 1603.22% in 2024.
  • Merck's Equity Average (Quarter) stood at $37.1 billion in 2021, then rose by 22.21% to $45.3 billion in 2022, then dropped by 12.86% to $39.5 billion in 2023, then grew by 15.2% to $45.5 billion in 2024, then rose by 11.04% to $50.5 billion in 2025.
  • Its Equity Average was $50.5 billion in Q3 2025, compared to $48.7 billion in Q2 2025 and $47.4 billion in Q1 2025.